Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer
Clinical trial NCT01889238 · COMPLETED
Trial details
- NCT number
- NCT01889238
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-12
- Primary completion
- 2015-03-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.